metergoline has been researched along with physostigmine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Duncton, MA; Emerling, DE; Kelly, MG; Nguyen, MT; Vincent, F | 1 |
| Gonzalez, RM; Holmgren, B; Rodriguez, R; Urba-Holmgren, R | 1 |
| Betti, R; Casanueva, FF; Cella, SG; Müller, EE | 1 |
| Bennett, JL; Pax, RA; Siefker, C | 1 |
| Holmgren, B; Urbá-Holmgren, R | 1 |
| Mohanakumar, KP; Muralikrishnan, D; Sarkar, S; Thomas, B | 1 |
9 other study(ies) available for metergoline and physostigmine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Topics: Amidohydrolases; Carbamates; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Piperazines; Stereoisomerism; Structure-Activity Relationship | 2009 |
Serotonergic modulation of yawning.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Metergoline; Physostigmine; Rats; Serotonin | 1979 |
Activation of the cholinergic system and growth hormone release in the dog: functional interactions with other neurotransmitters.
Topics: Animals; Behavior, Animal; Cimetidine; Clemastine; Diphenhydramine; Dogs; Domperidone; Female; Fenfluramine; Growth Hormone; Male; Metergoline; Naloxone; Phentolamine; Physostigmine; Pimozide; Pizotyline; Propranolol; Radioimmunoassay; Receptors, Cholinergic; Synaptic Transmission | 1985 |
Schistosoma mansoni: differences in acetylcholine, dopamine, and serotonin control of circular and longitudinal parasite muscles.
Topics: Acetylcholine; Animals; Atropine; Carbachol; Dopamine; Magnesium; Male; Metergoline; Muscle Contraction; Physostigmine; Schistosoma mansoni; Serotonin; Spiperone | 1984 |
Interaction of cholinergic and dopaminergic influences on yawning behavior.
Topics: Animals; Apomorphine; Behavior, Animal; Benzofurans; Citalopram; Fluoxetine; Metergoline; Physostigmine; Propylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Scopolamine; Spiperone | 1980 |
Effects of serotoninergic drugs on tremor induced by physostigmine in rats.
Topics: Animals; Buspirone; Cholinesterase Inhibitors; Cyproheptadine; Metergoline; N,N-Dimethyltryptamine; Physostigmine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Tetrahydronaphthalenes; Tremor | 2000 |